← brief for 2026-10-24 · Slowing decline

Renal Safety and Antiviral Effectiveness of Tenofovir Alafenamide Versus Entecavir in Patients With Chronic Hepatitis B and Chronic Kidney Disease: A Real‐World Cohort Study

Article C Peer reviewed Observational

Key takeaways

This study compared two hepatitis B drugs in 54 people who already had kidney disease. It looked at kidney function over 48 weeks. The results show a link between the drugs and kidney safety, but it is not proof that one drug is better than the other.

Who did this work

Danfeng Ren (Xi'an Medical University) · Xiangyun Dang (Xi'an Medical University) · Shan Fu (Xi'an Medical University) · Ze Zhang (Xi'an Medical University) · Tianzhi Ni (Xi'an Medical University) · Wentao Zhang (Xi'an Medical University) · 赵英仁 (Xi'an Medical University) · Jinfeng Liu (Xi'an Medical University)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-23
https://doi.org/10.1111/jvh.70235